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Abstract 
The proper regulation of gene expression is critical to many biological processes 
occurring in the cell. It is becoming increasingly apparent that post-transcriptional processing 
pathways play significant roles in regulating the expression of various genes in both 
prokaryotic and eukaryotic organisms, where they direct a variety of complex cellular 
functions. A striking example of a biological communication and control system directing 
sophisticated gene expression regulation through precise molecular recognition is the class of 
RNA regulatory elements, called riboswitches, comprised of distinct sensor (ligand-binding) 
and actuator (gene-regulatory) functions that control gene expression in response to changing 
levels of specific target ligand concentrations.   
Inspired by these natural examples, numerous synthetic riboswitch systems have been 
developed and have made profound contribution to the field of riboswitch engineering. 
However, these early examples of synthetic riboswitches pose one or more challenges, such 
as portability of the switch design across different cellular systems and modularity and 
programmability of the components comprising the switch molecule. Therefore, we set out to 
develop a modular and extensible RNA-based gene-regulatory platform that will provide a 
 v
 framework for the reliable design and construction of gene regulatory systems that can 
control the expression of specific target genes in response to effector molecules of interest. 
The platform is called the “ribozyme switch” and composed of distinct functional 
components, which are modularly coupled and functionally independent of each other. 
Through this platform, ribozyme switch devices that enable up- or down-regulation of target 
gene expression were developed. Design modularity and response programmability of the 
switch platform were also demonstrated. We also exhibited the versatility of the platform in 
implementing application-specific control systems for small molecule-mediated regulation of 
cell growth and non-invasive in vivo sensing of metabolite production.  
Through the ribozyme switch platform, we further constructed higher-order RNA 
devices that enable complex cellular information processing operations, including logic 
control (AND, NOR, and NAND gates), advanced computation (bandpass filter and signal 
shift in the output swing), and cooperativity (signal gain). Finally, we extended the small 
ribozyme switch platform responsive to small molecules to a different class of ligand 
molecules, proteins, by developing protein-responsive gene regulators and cellular biosensors. 
In addition to engineering RNA devices for programming cellular function, we also 
developed a high-throughput method for functional characterization of small molecule-
binding RNA aptamers, which enables robust, accurate, and rapid characterization of such 
RNA aptamers. This method can be very useful as we (and others) develop RNA aptamers 
for small molecules of specific interest, which can be subsequently integrated into the 
ribozyme switch platform as sensing elements for specific applications. Together, these 
research developments hold synergistic values for the reliable construction of ‘designer’ 
gene-regulatory systems for various biotechnological and medical applications. 
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